Englitazone is a
hypoglycemic
Hypoglycemia, also called low blood sugar, is a fall in blood sugar to levels below normal, typically below 70 mg/dL (3.9 mmol/L). Whipple's triad is used to properly identify hypoglycemic episodes. It is defined as blood glucose belo ...
agent of
thiazolidinedione
The thiazolidinediones , abbreviated as TZD, also known as glitazones after the prototypical drug ciglitazone, are a class of heterocyclic compounds consisting of a five-membered C3NS ring. The term usually refers to a family of drugs used in ...
(''glitazone'') class.
See also
*
Ciglitazone
Ciglitazone (INN) is a thiazolidinedione. Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class.
Ciglitazone was never used as a medication, but it sparked interest in t ...
*
Darglitazone
Darglitazone (previously known as CP 86325-2) is a member of the class of drugs and an agonist of Peroxisome proliferator-activated receptor gamma, peroxisome proliferator-activated receptor-γ (PPAR-γ), an orphan member of the nuclear receptor ...
*
Netoglitazone
Netoglitazone (also called MCC-555) is a hypoglycemic agent belonging to the thiazolidinedione
The thiazolidinediones , abbreviated as TZD, also known as glitazones after the prototypical drug ciglitazone, are a class of heterocyclic comp ...
*
Troglitazone
Troglitazone is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for people with diabetes mellitus type 2.
It was patented in 1983 and approved for medical use in 1997. It ...
*
Rivoglitazone
Rivoglitazone (INN) is a thiazolidinedione derivative undergoing research for use in the treatment of type 2 diabetes.
It is being developed by Daiichi Sankyo
is a global pharmaceutical company and the second-largest pharmaceutical company in ...
—currently in clinical trials
*
Pioglitazone,
lobeglitazone
Lobeglitazone (trade name Duvie, Chong Kun Dang) is an antidiabetic drug in the thiazolidinedione class of drugs. As an agonist for both PPARα and PPARγ, it works as an insulin sensitizer by binding to the PPAR receptors in fat cells and ma ...
,
rosiglitazone—the only ones currently in clinical use
References
{{PPAR modulators
Chromanes
Thiazolidinediones